214 related articles for article (PubMed ID: 3310871)
21. Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
Brunet F; Lanore JJ; Dhainaut JF; Dreyfus F; Huyghebaert MF; Varet B; Monsallier JF
Drugs; 1988; 35 Suppl 2():195. PubMed ID: 3396480
[No Abstract] [Full Text] [Related]
22. The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts.
Greene WH
Bull N Y Acad Med; 1984 May; 60(4):426-38. PubMed ID: 6372918
[No Abstract] [Full Text] [Related]
23. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
Gaya H; Klastersky J; Schimpff SC; Tattersall MH
Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
[No Abstract] [Full Text] [Related]
24. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
[TBL] [Abstract][Full Text] [Related]
25. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
Papayannis AG; Thomopoulos D; Voulgaris E; Scliros P; Gardikas C
J Antimicrob Chemother; 1977 Jul; 3(4):311-5. PubMed ID: 893240
[No Abstract] [Full Text] [Related]
26. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and treatment of infection in the support of the neutropenic patient].
Rafecas FJ; Sanz MA; Martín-Aragones G; Martínez JA; Sayas MJ; Marty ML
Sangre (Barc); 1985; 30(4-B):501-14. PubMed ID: 4081964
[No Abstract] [Full Text] [Related]
28. Review of amikacin usage in the EORTC trials.
Zinner SH
Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
[TBL] [Abstract][Full Text] [Related]
29. Management of bacterial infections in severely neutropenic subjects.
Vincent PC; Fabre S; Jennis F
Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
[TBL] [Abstract][Full Text] [Related]
30. Antibiotics for the treatment of febrile children with neutropenia and cancer.
Rubin M; Pizzo PA
N Engl J Med; 1989 Apr; 320(14):939. PubMed ID: 2927469
[No Abstract] [Full Text] [Related]
31. Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy.
Johnson MP; Ramphal R
J Infect Dis; 1990 Oct; 162(4):981-3. PubMed ID: 2205658
[TBL] [Abstract][Full Text] [Related]
32. Fever and neutropenia in children with neoplastic disease: an analysis of 158 episodes.
Nachman JB; Honig GR
Cancer; 1980 Jan; 45(2):407-12. PubMed ID: 7351024
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic therapy in cancer patients with fever and neutropenia.
N Engl J Med; 1987 Feb; 316(7):410-2. PubMed ID: 3543678
[No Abstract] [Full Text] [Related]
34. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
35. Role of antimicrobial combinations in the therapy of infections in neutropenic patients.
Gialdroni Grassi G; Grassi C
Chemioterapia; 1987 Jun; 6(2 Suppl):398-400. PubMed ID: 3334582
[No Abstract] [Full Text] [Related]
36. Management of infections in immunocompromised cancer patients.
Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
[No Abstract] [Full Text] [Related]
37. [Infection in patients with granulocytopenia. Therapeutic results of 3 different antimicrobial programs in 162 febrile episodes].
Avilés Miranda A; Conte Lanza G; Sinco Angeles A; Ambriz Fernández R; Pizzuto J
Sangre (Barc); 1982; 27(3):324-32. PubMed ID: 7157128
[No Abstract] [Full Text] [Related]
38. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC
Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217
[TBL] [Abstract][Full Text] [Related]
39. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
Verhagen C; De Pauw BE; Williams KJ; Du Bois W
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):178-82. PubMed ID: 3134208
[TBL] [Abstract][Full Text] [Related]
40. Controversies in the management of febrile neutropenic cancer patients.
Rubin M; Hathorn JW; Pizzo PA
Cancer Invest; 1988; 6(2):167-84. PubMed ID: 3132310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
